Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

NCT01497184 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

PROCEDURE: HSCT
GENETIC: DLI

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]